Related Experiment Video
Updated: Aug 18, 2026

Pre-clinical Model of Cardiac Donation after Circulatory Death
Published on: August 2, 2019
Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694
1Department of Cardiovascular Surgery, University of Western Ontario, London, Canada.
Insights
Inhibiting sodium-hydrogen exchanger (Na+/H+) with HOE 694 significantly protects rabbit hearts from damage after 12-hour hypothermic storage. This finding suggests antiport inhibitors are effective for myocardial preservation.
Area of Science:
- Cardiology
- Cell Physiology
- Biochemistry
Background:
- Na+/H+ exchange is crucial for cardiac pH regulation.
- This exchange mechanism can paradoxically cause tissue damage in reperfused myocardium.
- Investigated the protective potential of a selective Na+/H+ exchange inhibitor, HOE 694.
Purpose of the Study:
- To evaluate the efficacy of HOE 694 in preventing myocardial damage after prolonged hypothermic storage.
- To determine the optimal timing for HOE 694 administration (cardioplegia vs. reperfusion).
Main Methods:
- Isolated rabbit hearts underwent 12-hour hypothermic (4°C) ischemic arrest followed by 60-minute reperfusion (37°C).
- HOE 694 was administered during cardioplegia and/or reperfusion.
- Left ventricular function, creatine kinase release, and high-energy phosphate content were assessed.
Main Results:
- HOE 694 treatment significantly improved systolic function recovery (approx. 80% vs. <40%) and reduced left ventricular end-diastolic pressure elevation.
- Administration during reperfusion was more effective than during cardioplegia alone.
- HOE 694 did not significantly alter tissue metabolite levels or creatine kinase release, except when added at reperfusion.
Conclusions:
- HOE 694 demonstrates a marked protective effect against myocardial injury following extended hypothermic ischemia.
- Na+/H+ exchange inhibitors show promise as a therapeutic strategy for myocardial preservation.
Background:
Na+/H+ exchange represents an important mechanism for pH regulation in the cardiac cell that, however, may paradoxically mediate tissue damage in the reperfused myocardium. We investigated whether inhibition of the exchanger can protect the heart against damage after prolonged hypothermic storage with the use of the selective inhibitor 3-methylsulfonyl-4-piperidinobenzoyl-guanidine methanesulfonate (HOE 694).
Methods:
After equilibration, isolated rabbit hearts were arrested with a 3 minute infusion of modified St. Thomas' cardioplegic solution and subsequently maintained in ischemic arrest at 4 degrees C for 12 hours before reperfusion at 37 degrees C for 60 minutes. Left ventricular function and creatine kinase release were measured at intervals throughout reperfusion. High-energy phosphate and adenine nucleotide content were determined in hearts before cardioplegia, at the end of the 12-hour storage period, and at the end of reperfusion. HOE 694 (1 mumol/L) was administered either with cardioplegia and throughout reperfusion (study 1) or selectively with either cardioplegia or reperfusion only (study 2).
Results:
In study 1, systolic function in untreated hearts recovered to less than 40% of preischemic values and was associated with a greater than 1,000% percent sustained elevation in left ventricular end-diastolic pressure. In contrast, systolic recovery in HOE 694-treated hearts was significantly accelerated and improved to approximately 80%, whereas left ventricular end-diastolic pressure increased to only 300% of baseline. Significant protection also occurred in those hearts in which HOE 694 was administered only at reperfusion while the drug was less effective if given only during cardioplegia. Creatine kinase release was not significantly affected except in study 2, where it was significantly lower after 60 minutes of reperfusion in hearts where HOE 694 was added at the time of reperfusion. Tissue metabolite content was not affected by drug treatment.
Conclusions:
This study shows a marked protective effect of the Na+/H+ exchange inhibitor HOE 694 in rabbit hearts subjected to 12 hours of hypothermic ischemia and strongly suggests that antiport inhibitors could play an effective role in myocardial preservation.
More Related Videos
08:22In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
08:15Innovative Strategies for Organ Preservation in Heart Transplantation: Uniform Cooling Preservation and Ex-situ Normothermic Perfusion
Published on: November 28, 2025